论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Antczak J, Kowalska K, Klimkowicz-Mrowiec A, Wach B, Kasprzyk K, Banach M, Rzeźnicka-Brzegowy K, Kubica J, Słowik A
Received 4 October 2017
Accepted for publication 15 January 2018
Published 13 March 2018 Volume 2018:14 Pages 749—755
DOI https://doi.org/10.2147/NDT.S153213
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Prof. Dr. Roumen Kirov
Peer reviewer comments 3
Editor who approved publication: Dr Roger Pinder
Background: Frontotemporal dementia (FTD) is one of the most frequent dementia types
in patients under 65 years of age. Currently, no therapy can effectively
improve the cognitive deficits associated with FTD. Repetitive transcranial
magnetic stimulation (rTMS) is a noninvasive method of inducing brain
plasticity with therapeutic potential in neurodegenerative diseases. The
purpose of this study was to evaluate the effect of rTMS on cognitive,
behavioral, and emotional function in FTD.
Methods: Nine patients (seven women, four men, mean age
61.7±10.1 years) with the behavioral variant of FTD, one with
nonfluent/agrammatic variant primary progressive aphasia, and one with
progressive nonfluent aphasia (subtypes of FTD) underwent 10 daily sessions of
10 Hz rTMS over the bilateral dorsolateral prefrontal cortex. Cognitive
and behavioral assessments were administered before and after therapy.
Results: After rTMS, the Montreal Cognitive Assessment
and letter and digit cancellation test scores, as well as reading time and
error number in the Stroop test improved. The caregivers’ impression of the
daily functioning of patients improved in the Frontal Behavioral Inventory
scores. These changes were not paralleled by an improvement of mood.
Conclusion: The results indicate that rTMS may improve the
cognitive performance of patients with FTD and warrant sham-controlled trials.
Keywords: frontotemporal
dementia, repetitive transcranial magnetic stimulation, Montreal Cognitive
Assessment
摘要视频链接:rTMSin frontotemporal
dementia